# Seres Therapeutics, Inc.: Form 8-K, filed Mar 16, 2026

- Company: [Seres Therapeutics, Inc.](/companies/mcrb.md) (CIK 1609809)
- Form: 8-K
- Filed: 2026-03-16
- Accepted by EDGAR: Mar 16, 2026, 16:42 ET
- Period: 2026-03-16
- Accession: 0001193125-26-108482
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1609809/000119312526108482/d47103d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1609809/000119312526108482/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1609809/000119312526108482/d47103d8k.htm

Filed Mar 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-108482. Last ingested by Listed: Nov 4, 2026, 10:08 ET. No prices; not investment advice.